Fingolimod -Response According to Coping - Evaluation

PHASE4CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

fingolimod

Trial Locations (47)

13008

Novartis Investigative Site, Marseille

13012

Novartis Investigative Site, Marseille

17019

Novartis Investigative Site, La Rochelle

21034

Novartis Investigative Site, Dijon

21240

Novartis Investigative Site, Talant

29240

Novartis Investigative Site, Brest

31059

Novartis Investigative Site, Toulouse

31243

Novartis Investigative Site, Saint-Jean

32900

Novartis Investigative Site, Nîmes

34000

Novartis Investigative Site, Montpellier

34170

Novartis Investigative Site, Castelnau-le-Lez

34295

Novartis Investigative Site, Montpellier

34525

Novartis Investigative Site, Béziers

35033

Novartis Investigative Site, Rennes

37044

Novartis Investigative Site, Tours

37175

Novartis Investigative Site, Chambray-lès-Tours

38042

Novartis Investigative Site, Grenoble

42328

Novartis Investigative Site, Roanne

47923

Novartis Investigative Site, Agen

49033

Novartis Investigative Site, Angers

49400

Novartis Investigative Site, Saumur

50100

Novartis Investigative Site, Cherbourg

51092

Novartis Investigative Site, Reims

57085

Novartis Investigative Site, Metz

59200

Novartis Investigative Site, Tourcoing

62107

Novartis Investigative Site, Calais

63003

Novartis Investigative Site, Clermont-Ferrand

64109

Novartis Investigative Site, Bayonne

67091

Novartis Investigative Site, Strasbourg

67500

Novartis Investigative Site, Hagueneau

69110

Novartis Investigative Site, Sainte-Foy-lès-Lyon

69275

Novartis Investigative Site, Lyon

72037

Novartis Investigative Site, Le Mans

75005

Novartis Investigative Site, Paris

76550

Novartis Investigative Site, Saint-Aubin-sur-Scie

80054

Novartis Investigative Site, Amiens

83500

Novartis Investigative Site, La Seyne-sur-Mer

84000

Novartis Investigative Site, Avignon

86021

Novartis Investigative Site, Poitiers

88021

Novartis Investigative Site, Épinal

89000

Novartis Investigative Site, Auxerre

91401

Novartis Investigative Site, Orsay

93009

Novartis Investigative Site, Bobigny

94010

Novartis Investigative Site, Créteil

94275

Novartis Investigative Site, Le Kremlin-Bicêtre

Unknown

Novartis Investigative Site, Limoges

F-95300

Novartis Investigative Site, Pontoise

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY